Whether in nuclear medicine or working with the NCAA, Scott has always been part of the action at UAB
Daryl Green, Ph.D., chief of UAB Police and AVP of Public Safety, has been on campus for 20 months — here is how the force has changed under his watch and what he wants to share with all UAB employees.
UAB Police holds promotion ceremony
Healthy Women Needed for a Research Study
For information, call us at 205-934-5498 or email Stephanie Ford at smford@uabmc.edu
The Green Labs and Rheaply programs at UAB have earned a Department of Energy Better Practice Awards honor — one of only two universities to receive the award. Another recognition brings pro bono consulting on electrification of Blazer Express.
A Phase 3, Randomized, Multicenter, Open-label Study to Investigate the Efficacy and Safety of Retatrutide Once Weekly Compared with Semaglutide Once Weekly in Adult Participants with Type 2 Diabetes and Inadequate Glycemic Control with Metformin with or without SGLT2 Inhibitor (TRANSCEND-T2D-2)
TRANSCEND-T2D-2 is a clinical research study for people with type 2 diabetes.
This study will test if an investigational medicine (the medicine being studied) can
help with blood glucose (sugar) and weight management compared with an existing
treatment for type 2 diabetes.
- Are aged 18 years or older
- Have type 2 diabetes
- Have been taking 1500mg or more of metformin each day for at least 3 months (with or without SGLT2i)
- Have a BMI of 25 or more
- Have HbA1c levels of 7.0% to 10.5%
To see if you qualify please contact at 205-996-4015, 205-934-5564 or via mail at tthoma@uab.edu or ccnrn@uab.edu
UAB Learning & Development Learn to Win Challenge Returns
Need new ideas? Try a walking meeting
Starting small and making a plan with a crew can help Blazers with desk jobs stay active — and one employee from the School of Education says walking meetings have changed the game for her and her team.
Diagnosed with depression? Your mental health matters.
We're conducting clinical research in depression to learn how individuals’ brain biology impacts response to treatment, with the goal to help people find relief faster. You do not need to already have a diagnosis to participate.
If you’re currently taking medication, you are likely still eligible for our studies and don’t have to stop your existing treatment regimen.
For more information about this trial and to see if you qualify, please contact Kristine at kristinepike@uabmc.edu or 205-975-8542.
